Cetera Investment Advisers’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.03M | Sell |
24,058
-6,077
| -20% | -$1.51M | 0.01% | 1380 |
|
|
2025
Q4 | $8.29M | Sell |
30,135
-679
| -2% | -$186K | 0.01% | 1143 |
|
|
2025
Q3 | $8.08M | Buy |
30,814
+6,423
| +26% | +$1.56M | 0.01% | 1120 |
|
|
2025
Q2 | $5.34M | Buy |
24,391
+941
| +4% | +$201K | 0.01% | 1150 |
|
|
2025
Q1 | $5.25M | Buy |
23,450
+2,879
| +14% | +$793K | 0.01% | 1082 |
|
|
2024
Q4 | $6.74M | Buy |
20,571
+1,239
| +6% | +$390K | 0.01% | 888 |
|
|
2024
Q3 | $5.8M | Sell |
19,332
-49
| -0.3% | -$15K | 0.01% | 935 |
|
|
2024
Q2 | $6.38M | Buy |
19,381
+391
| +2% | +$138K | 0.01% | 870 |
|
|
2024
Q1 | $7.51M | Buy |
18,990
+15,952
| +525% | +$5.9M | 0.02% | 783 |
|
|
2023
Q4 | $1.07M | Buy |
3,038
+78
| +3% | +$27.6K | 0.01% | 1072 |
|
|
2023
Q3 | $1.11M | Sell |
2,960
-366
| -11% | -$142K | 0.01% | 1000 |
|
|
2023
Q2 | $1.27M | Buy |
3,326
+79
| +2% | +$28.2K | 0.01% | 962 |
|
|
2023
Q1 | $1.13M | Sell |
3,247
-114
| -3% | -$33.3K | 0.01% | 977 |
|
|
2022
Q4 | $791K | Buy |
3,361
+396
| +13% | +$93.8K | 0.01% | 1105 |
|
|
2022
Q3 | $730K | Sell |
2,965
-185
| -6% | -$56.4K | 0.01% | 840 |
|
|
2022
Q2 | $952K | Sell |
3,150
-1,714
| -35% | -$558K | 0.02% | 819 |
|
|
2022
Q1 | $2M | Buy |
4,864
+207
| +4% | +$81K | 0.03% | 562 |
|
|
2021
Q4 | $2.18M | Sell |
4,657
-956
| -17% | -$412K | 0.03% | 523 |
|
|
2021
Q3 | $2.38M | Buy |
5,613
+996
| +22% | +$420K | 0.04% | 463 |
|
|
2021
Q2 | $1.66M | Buy |
4,617
+2,332
| +102% | +$770K | 0.03% | 580 |
|
|
2021
Q1 | $644K | Sell |
2,285
-1,439
| -39% | -$412K | 0.01% | 848 |
|
|
2020
Q4 | $1.05M | Buy |
+3,724
| New | +$1.05M | 0.02% | 641 |
|
Other funds holding WST
VCM
VPM
GIM
